首页    期刊浏览 2024年10月05日 星期六
登录注册

文章基本信息

  • 标题:Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision
  • 本地全文:下载
  • 作者:Alemayehu Hailu ; Getachew Teshome Eregata ; Amanuel Yigezu
  • 期刊名称:Cost Effectiveness and Resource Allocation
  • 印刷版ISSN:1478-7547
  • 电子版ISSN:1478-7547
  • 出版年度:2021
  • 卷号:19
  • DOI:10.1186/s12962-021-00312-5
  • 语种:English
  • 出版社:BioMed Central
  • 摘要:Cost-effectiveness of interventions was a criterion decided to guide priority setting in the latest revision of Ethiopia’s essential health services package (EHSP) in 2019. However, conducting an economic evaluation study for a broad set of health interventions simultaneously is challenging in terms of cost, timeliness, input data demanded, and analytic competency. Therefore, this study aimed to synthesize and contextualize cost-effectiveness evidence for the Ethiopian EHSP interventions from the literature. Methods The evidence synthesis was conducted in five key steps: search, screen, evaluate, extract, and contextualize. We searched MEDLINE and EMBASE research databases for peer-reviewed published articles to identify average cost-effectiveness ratios (ACERs). Only studies reporting cost per disability-adjusted life year (DALY), quality-adjusted life year (QALY), or life years gained (LYG) were included. All the articles were evaluated using the Drummond checklist for quality, and those with a score of at least 7 out of 10 were included. Information on cost, effectiveness, and ACER was extracted. All the ACERs were converted into 2019 US dollars using appropriate exchange rates and the GDP deflator. Results In this study, we synthesized ACERs for 382 interventions from seven major program areas, ranging from US$3 per DALY averted (for the provision of hepatitis B vaccination at birth) to US$242,880 per DALY averted (for late-stage liver cancer treatment). Overall, 56% of the interventions have an ACER of less than US$1000 per DALY, and 80% of the interventions have an ACER of less than US$10,000 per DALY. Conclusion We conclude that it is possible to identify relevant economic evaluations using evidence from the literature, even if transferability remains a challenge. The present study identified several cost-effective candidate interventions that could, if scaled up, substantially reduce Ethiopia’s disease burden. Supplementary Information The online version contains supplementary material available at 10.1186/s12962-021-00312-5.
  • 关键词:Cost-effectiveness analysis; Priorities setting; Essential health services package; Ethiopia
国家哲学社会科学文献中心版权所有